Application Note

Automated And Closed CTS DynaCellect Magnetic Separation System Delivers Target T Cell Isolation And Magnetic Bead Removal At High Efficiency

gibco 2

Successful commercial manufacturing of T cell therapies is essential to assuring the timely delivery of efficacious products to patients. However, the industry currently faces several key barriers that limit the capability to deliver the required volume of high-quality product for autologous therapies and developing allogeneic applications. Evaluate and explore a cell processing platform for T cell isolation and activation using magnetic beads that is supporting the cell therapy industry through these challenges.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene

Thermo Fisher Scientific Bioproduction